Patents by Inventor QIAOZHI WEI

QIAOZHI WEI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treatment by targeting VCAM1 and MAEA
    Patent number: 11732053
    Abstract: Antibodies and antibody fragments that inhibit the activity of vascular cell adhesion molecule 1 (VCAM1) and/or macrophage erythroblast attacher (MAEA) are provided, along with formulations and kits comprising these antibodies and antibody fragments and the use of the disclosed compositions, formulations, and kits to treat cancers, sickle cell disease, and Polycythemia Vera.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: August 22, 2023
    Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE
    Inventors: Paul S. Frenette, Sandra Pinho, Qiaozhi Wei
  • METHODS OF TREATMENT BY TARGETING VCAM1 AND MAEA
    Publication number: 20230212295
    Abstract: Antibodies and antibody fragments that inhibit the activity of vascular cell adhesion molecule 1 (VCAM1) and/or macrophage erythroblast attacher (MAEA) are provided, along with formulations and kits comprising these antibodies and antibody fragments and the use of the disclosed compositions, formulations, and kits to treat cancers, sickle cell disease, and Polycythemia Vera.
    Type: Application
    Filed: December 27, 2022
    Publication date: July 6, 2023
    Inventors: Paul S. FRENETTE, Sandra PINHO, Qiaozhi WEI, Sung Kyun LEE
  • Methods of treatment by targeting VCAM1 and MAEA
    Patent number: 11560433
    Abstract: Antibodies and antibody fragments that inhibit the activity of vascular cell adhesion molecule 1 (VCAM1) and/or macrophage erythroblast attacher (MAEA) are provided, along with formulations and kits comprising these antibodies and antibody fragments and the use of the disclosed compositions, formulations, and kits to treat cancers, sickle cell disease, and Polycythemia Vera.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: January 24, 2023
    Assignee: Albert Einstein College of Medicine
    Inventors: Paul S. Frenette, Sandra Pinho, Qiaozhi Wei, Sung Kyun Lee
  • METHODS OF TREATMENT BY TARGETING VCAM1 AND MAEA
    Publication number: 20210095045
    Abstract: Antibodies and antibody fragments that inhibit the activity of vascular cell adhesion molecule 1 (VCAM1) and/or macrophage erythroblast attacher (MAEA) are provided, along with formulations and kits comprising these antibodies and antibody fragments and the use of the disclosed compositions, formulations, and kits to treat cancers, sickle cell disease, and Polycythemia Vera.
    Type: Application
    Filed: October 1, 2020
    Publication date: April 1, 2021
    Applicant: Albert Einstein College of Medicine
    Inventors: Paul S. FRENETTE, Sandra PINHO, Qiaozhi WEI
  • METHODS OF TREATMENT BY TARGETING VCAM1 AND MAEA
    Publication number: 20200270349
    Abstract: Antibodies and antibody fragments that inhibit the activity of vascular cell adhesion molecule 1 (VCAM1) and/or macrophage erythroblast attacher (MAEA) are provided, along with formulations and kits comprising these antibodies and antibody fragments and the use of the disclosed compositions, formulations, and kits to treat cancers, sickle cell disease, and Polycythemia Vera.
    Type: Application
    Filed: January 27, 2020
    Publication date: August 27, 2020
    Applicant: Albert Einstein College of Medicine
    Inventors: Paul S. FRENETTE, Sandra PINHO, Qiaozhi WEI, Sung Kyun LEE
  • METHODS FOR TREATING CANCER BY TARGETING VCAM1 AND MAEA
    Publication number: 20190077878
    Abstract: Methods are disclosed for treating cancers using antibodies and antibody fragments that inhibit the activity of Vascular cell adhesion molecule 1 (Vcam1) and/or Macrophage erythroblast attacher (Maea).
    Type: Application
    Filed: November 26, 2018
    Publication date: March 14, 2019
    Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
    Inventors: PAUL S. FRENETTE, SANDRA PINHO, QIAOZHI WEI